Nomura Holdings Reports Strong Nine-Month Financials and Details Macquarie Acquisition Impact
Summary
Nomura Holdings reported strong financial results for the nine months ended December 31, 2025, with significant revenue and net income growth, and provided detailed insights into the recently completed $1.8 billion Macquarie acquisition.
Key Events
-
Strong Nine-Month Financial Performance
Nomura reported net revenue of 1,590.5 billion yen, a 10.5% increase year-over-year, and net income attributable to shareholders of 288.2 billion yen for the nine months ended December 31, 2025, with an annualized Return on Equity (ROE) of 10.8%.
-
Macquarie Acquisition Details Confirmed
The company finalized the acquisition of Macquarie Management Holdings, Inc. on December 1, 2025, for approximately $1.8 billion (281.4 billion yen), significantly boosting Assets Under Management by 50.8% to 134.7 trillion yen in the Investment Management segment.
-
Healthy Capital Position Maintained
Nomura's Tier 1 Capital increased to 3,637 billion yen, and the Consolidated Capital Adequacy ratio stood at 15.8%, demonstrating a solid financial foundation despite slight decreases in some capital ratios compared to March 31, 2025.
-
Segmental Growth Across Key Businesses
Wealth Management net revenue increased by 6.3%, Wholesale net revenue grew by 6.9% driven by strong Equities performance, and Banking net revenue rose by 10.2%, indicating broad-based operational strength.
Analysis
This 6-K filing provides comprehensive financial highlights for the nine months ended December 31, 2025, detailing the robust performance previously announced. The report confirms significant growth in net revenue and net income, alongside a healthy return on equity. Crucially, it elaborates on the strategic acquisition of Macquarie Management Holdings, Inc. for approximately $1.8 billion, outlining its impact on the Investment Management segment. While some capital ratios saw minor adjustments, the overall capital position remains strong. Investors should view this detailed report as a confirmation of the company's positive trajectory and strategic expansion, providing granular data supporting the previously disclosed headline figures.
At the time of this filing, NMR was trading at $8.68 on NYSE in the Finance sector, with a market capitalization of approximately $25.4B. The 52-week trading range was $4.86 to $9.47. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.